These data demonstrate a novel disease mechanism by which RBC drive postischemic cardiac dysfunction in type 2 diabetes.
SUMMARY
This study tested the hypothesis that red blood cell (RBC) arginase represents a potential therapeutic target in ischemia-reperfusion in type 2 diabetes. Post-ischemic cardiac recovery was impaired in hearts from db/db mice compared with wild-type hearts. RBCs 
I
t is well established that type 2 diabetes is an important risk factor for development of myocardial infarction (1, 2) and for poor outcome following an acute coronary event (3) . A key component contributing to cardiovascular complications including ischemic heart disease in type 2 diabetes is an altered vascular homeostasis involving reduced bioavailability of nitric oxide (NO) and increased oxidative stress (1,2,4-7). The mechanisms behind reduced bioavailability of NO are complex and involve both reduced production by endothelial nitric oxide synthase (eNOS) and increased inactivation of NO by up-regulation of reactive oxygen species (ROS). Previously it has been demonstrated that an important regulator of NO production is arginase, which competes with eNOS for their common substrate L-arginine (8, 9) . Arginase may also trigger formation of ROS by inducing uncoupling of NOS, a condition in which eNOS produces superoxide instead of NO (4, (9) (10) (11) . By these mechanisms increased arginase activity is suggested to contribute to cardiovascular dysfunction.
The source of these actions of arginase in the cardiovascular system has until recently been considered to be the endothelium (8, 12) . Of importance, we have recently demonstrated that arginase 1 expressed in red blood cells (RBCs) serves as a critical regulator of the formation and export of cardioprotective NO-like bioactivity produced by RBCs eNOS during ischemia-reperfusion (13) . This novel source and effect of arginase was shown to be of importance for cardiac function. Thus, inhibition of RBCs arginase protects the heart from ischemia-reperfusion injury via an eNOS-dependent mechanism.
Additionally, in vivo observations support a role of RBC eNOS during myocardial ischemia-reperfusion (14) . However, the pathophysiological role of arginase as a regulator of NO bioavailability and ROS production in RBCs in the setting of myocardial ischemiareperfusion under conditions with increased arginase activity remains unknown. Interestingly, increased arginase activity has emerged as an important regulator of NO formation and ROS production in diabetes (15, 16) . Furthermore, a previous study has suggested that arginase is up-regulated in RBCs from patients with diabetes (17). Therefore, it is conceivable to assume that up-regulation of RBC arginase in diabetes is of functional importance for the susceptibility to myocardial ischemia-reperfusion injury. Based on these considerations, we tested the hypothesis that up-regulation of RBC arginase is a key HEART ISOLATION AND PERFUSION. Following anesthesia, hearts were isolated from WT as well as db/db mice and Wistar rats and perfused in a Langendorff system (18, 19) . After stabilization, the hearts were subjected to 25 min (rat hearts) or 40 min (mouse hearts) global ischemia followed by 60 min reperfusion (Supplemental Figure 1) .
RBCs from mice were administered to isolated mouse hearts. Immediately following the onset of ischemia by clamping the inflow tube, 0.4 ml KrebsHenseleit (KH) buffer or RBC suspension was injected into the coronary circulation via a side arm in the perfusion system (Supplemental Figure 1 ). This method allowed the RBC suspension to be present in the hearts during the ischemic period and was washed away by the reperfusion. The buffer and RBC suspension were incubated with vehicle, the arginase inhibitors N u -hydroxy-nor-L-arginine (nor-NOHA, 1 and 3 mmol/l) and 2 (S)-amino-6-boronohexanoic acid ([ABH], 1 mmol/l), the NOS inhibitor N G -nitro-L-arginine methyl ester ([L-NAME], 0.1 mmol/l) or the combination of nor-NOHA and L-NAME for 20 min at 37 C before being administered to the hearts. When NOS and arginase inhibition were combined, L-NAME was added to the RBC suspension 5 min prior to nor-NOHA. Nor-NOHA and ABH are structurally different arginase inhibitors whereby nor-NOHA has a guanidinium chain, whereas ABH binds as a tetrahedral boronate anion (20) . The concentrations were determined from pilot experiments using different concentrations of nor-NOHA demonstrating 1 mmol/l as an effective concentration and a previous publication (13) .
RBCs from humans were administered in a volume of 3 ml to isolated rat hearts as described for mouse hearts. In addition, the role of the inducible isoform of NOS (iNOS) in human RBC was investigated using the specific iNOS inhibitor 1400W (0.1 mmol/l). 
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RESULTS MOUSE STUDIES. B a s e l i n e c h a r a c t e r i s t i c s .
Body weight of db/db mice (n ¼ 12) was higher than that of WT mice (n ¼ 11) (51.4 AE 5.5 g vs. 28.8 AE 1.9 g; p < 0.001), whereas the mean heart weight was lower than that of WT mice (0.12 AE 0.01 g vs. 0.15 AE 0.02 g; p < 0.001). The heart weight-body weight ratio was significantly lower in db/db mice than in WT mice (0.0023 AE 0.0003 vs. 0.0054 AE 0.0007; p < 0.001).
Baseline functional characteristics of the isolated hearts in the different study groups are shown in Supplemental Table 2 . Yang et al. RBCs is used as standard in B to F. Significant differences are shown; *p < 0.05, **p < 0.01, and ***p < 0.001. Abbreviations as in Figure 1 .
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HUMAN STUDY. B a s a l c h a r a c t e r i s t i c s . Basal clinical characteristics of patients with type 2 diabetes
and age-matched healthy subjects are shown in Supplemental Table 1 . The patients with type 2 diabetes had higher body mass index, fasting glucose, glycated hemoglobin, and triglycerides, while they had lower total cholesterol, high-density lipoprotein, and low-density lipoprotein cholesterol in comparison with the healthy subjects. None of the healthy subjects was on medication. pressure (LVDP) is expressed as percentage recovery from the pre-ischemic level. Significant differences between groups in A to C were analyzed using 2-way analysis of variance including all time points, whereas Student's t-test was performed in D; *p < 0.05 and ***p < 0.001. Abbreviations as in Figure 1 . from WT mice incubated with vehicle (n ¼ 6) or L-NAME (0.1 mmol/l, n ¼ 5). Post-ischemic LVDP is expressed as percentage recovery from the pre-ischemic level. Significant differences between treatments were analyzed using 2-way analysis of variance including all time points; ***p < 0.001. Abbreviations as in Figures 1 to 4 .
R O S p r o d u c t i o n i s i n c r e a s e d i n R B C s f r o m p a t i e n t s w i t h t y p e 2 d i a b e t e s a n d i
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myocardial functional recovery. These data demonstrate a novel disease mechanism in type 2 diabetes by which RBC impair post-ischemic cardiac function. This effect is driven by up-regulation of RBC arginase 1 that induces a NOS-dependent increase in ROS production. Figures 1, 2 , and 4.
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Red Blood Cells and Cardiac Function in Diabetes (23, 24) . It has long since been suggested that RBCs export bioactive NO (25) and that RBCs contain eNOS protein (26) . However, it has been seriously questioned whether eNOS-derived NO is functionally active because it is expected to be rapidly scavenged by hemoglobin (27, 28) . It is therefore of interest that RBCs were shown to protect the isolated heart from ischemia-reperfusion injury via a NOS-dependent mechanism (29) . Furthermore, mice with blood cells lacking eNOS have lower circulating nitrite and nitrate levels and develop larger infarcts following ischemia-reperfusion than control mice, supporting a role of RBC eNOS also under in vivo conditions (14, 30) . In a recent study, we demon- 
